Integrated hand-powered centrifugation and paper-based diagnosis with blood-in/answer-out capabilities

Bowei Li,Ji Qi,Longwen Fu,Jinglong Han,Jaebum Choo,Andrew J deMello,Bingcheng Lin,Lingxin Chen,Andrew J. deMello

DOI: https://doi.org/10.1016/j.bios.2020.112282

IF: 12.545

2020-10-01

Biosensors and Bioelectronics

Abstract:<p>To date, 55% of inhabitants of the developing world still live in rural regions and they have a very urgent need to improve the level of disease diagnosis, especially in resource-limited settings. Herein, we present a microfluidic system that centrifuges whole blood and quantifies contained biomarkers in a rapid, feasible and integrated way. Such a device provides a blood-in/answer-out capability and is small enough to be carried by any individual in any environment. The successful integration a hand-powered centrifuge and immunoassay unit within a rotational paper-based device allows for diagnostic application by untrained users and in environments where access to electricity cannot be assumed. In addition, the low cost (∼$ 0.5), light weight and small instrumental footprint make the device ideally suited for rapid on-site detection. To validate the applicability of the system in a clinical diagnostic testing, we successfully perform enzyme-linked immunosorbent assay (ELISA) analysis of carcinoembryonic antigen and alpha fetoprotein from human blood samples. We expect that this powerful platform technology will provide the opportunities for point-of-care diagnosis in resource-limited settings.</p>

biotechnology & applied microbiology,biophysics,chemistry, analytical,electrochemistry,nanoscience & nanotechnology

What problem does this paper attempt to address?

The paper aims to address the issue of rapid, low-cost, and easy-to-operate disease diagnosis in resource-limited settings, particularly in rural areas of developing countries. These regions have an urgent need to improve disease diagnosis levels but often lack electricity supply, and medical equipment is expensive, bulky, and difficult to popularize. To this end, the research team developed a microfluidic system capable of manually centrifuging whole blood and rapidly quantifying biomarkers on a paper-based platform. This system integrates a manually driven centrifuge device and an immunoassay unit, achieving the "blood input/result output" function, and is small in size and low in cost (about $0.5), making it suitable for personal carrying and on-site use. Additionally, the system does not rely on electricity and can be operated without professional training, making it particularly suitable for environments where electricity supply cannot be guaranteed. To verify the clinical application potential of the system, the research team successfully used it to perform enzyme-linked immunosorbent assay (ELISA) analysis of carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in human blood samples. The researchers believe that this technological platform is expected to provide new opportunities for point-of-care diagnosis in resource-limited areas.